Cancer Detection Blood Test Equipment
-
Manufactured by 20/20 GeneSystems Inc.based in USA
20/20 GeneSystems developed PAULA’s Test, a blood test for early detection of lung cancer. It is available in the USA through licensed medical professionals. Testing is performed at 20/20’s CLIA licensed laboratory, Genesys Biolabs (CLIA Lic# 21D2037411). PAULA’s ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
AlphaLiquid® Screening is a blood-based test for early detection of multiple cancers. With 10mL of blood, the test analyzes genetic and epigenetic features in cfDNA to screen for signals of cancer as well as predict the tissue of origin. ...
-
Manufactured by Provista Diagnosticsbased in USA
A simple blood test to detect breast cancer with high accuracy in women with abnormal imaging findings. Coming in 2023 the only blood test to rule out breast cancer with >98% accuracy in women with suspicious imaging findings, irrespective of breast ...
-
Manufactured by 20/20 GeneSystems Inc.based in USA
Comprehensive health screening, something common in many countries outside of the U.S. has been something that is rarely accessible for most Americans. By placing a high priority on early detection, most cancers can be survivable when detected early enough to be surgically removed. Now, 20/20 is bringing a new blood ...
-
Manufactured by Epigenomics AGbased in GERMANY
as a blood draw. The test is performed by a clinical laboratory. It detects a specific type of DNA called Septin9, which is altered in colorectal cancer tumor cells more often than in normal cells. Epi proColon® is the first and only FDA-approved blood-based test for the ...
-
Manufactured by Amadixbased in SPAIN
PreveCol, an innovative blood-based test for early colorectal cancer detection. PreveCol is an innovative test based on an algorithm that combines the clinical characteristics identified by Artificial Intelligence with the analysis of biomarker levels in plasma for the early detection of ...
-
Manufactured by Hipro Biotechnology Co.,Ltd.based in CHINA
Zoan Fecal Occult Blood / Transferrin Combo Test Kit. Highlights:Early Bowel Cancer Screening, No pain & Non-invasive Detection, Fast Result in 5 Minutes, Home Test, Combined Test-2 result in 1 test, Easy operation with integrated design, Clean and Odourless, High ...
-
Manufactured by IMB Dx, Inc.based in SOUTH KOREA
AlphaLiquid®100 is a test that enables the detection of biomarkers which can predict the efficacy/resistance of targeted therapy for one blood test across 118 cancer-related genes. During cancer patients’ treatment journey, a simple blood draw can be used to support ...
-
Manufactured by INOVIQ Ltdbased in AUSTRALIA
INOVIQ has three autoantibody tests in development for early detection of ovarian, breast and lung cancers. BARD1 autoantibody tests measure autoantibodies to variant BARD1 proteins in the blood and use a proprietary cancer-specific algorithm to combine these levels into a cancer ...
-
based in USA
Demonstrated extremely high sensitivity for multiple biological analytes, including: COVID-19 virus detection as sensitive as 5 TCID50, rivalling PCR sensitivity, Early liver cancer biomarker test detects target protein biomarker in as little as 5 microliters of blood. Chemical development and prototyping ...
-
Manufactured by BTNX Inc.based in CANADA
The Rapid Response Fecal Immunochemical Test (FIT) Cassette is a rapid, qualitative test for the determination of human occult blood in feces, to aid in the early detection of gastrointestinal problems such as colorectal cancer. Traditional guaiac-based methods to detect fecal occult ...
-
Manufactured by PREVENTIS GMBHbased in GERMANY
or a precancerous lesion. With a colonoscopy, the stool test has been shown to reduce the risk of dying from colorectal cancer. The Preventis SmarTest® FIT Home test system consists of a rapid immunological test and a smartphone app. The rapid test detects human blood in ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you